# Nanjing Immunophage Biotech

Source: https://onco.cc/companies/nanjing-immunophage-biotech/  
OnCo record `nanjing-immunophage-biotech` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Nanjing Immunophage Biotech is a Chinese developer in Nanjing that sponsors 2 registered cancer trials of IPG1094 and IPG7236.

## Summary

Nanjing Immunophage Biotech appears on ClinicalTrials.gov as the industry sponsor of 2 interventional cancer trials (phase 1/2), testing IPG1094, IPG7236, Toripalimab in solid tumor, advanced solid tumor. OnCo records the company from the registry alone: the head office city comes from its registered name, and there are no website, funding or approval claims until they are sourced.

## Fields

- Kind: Company
- Last checked: 2026-09-11
- Also known as: Nanjing Immunophage Biotech Co., Ltd
- Tags: ctgov-sponsor; china; registry-only
- HQ: Nanjing, China
- Type: biotech

## Sources

- ClinicalTrials.gov: trials sponsored by Nanjing Immunophage Biotech: https://clinicaltrials.gov/search?spons=Nanjing%20Immunophage%20Biotech

## Connected records

- trials: [IPG7236 Combined With Toripalimab in Participants With Advanced Solid Tumors](https://onco.cc/trials/nct07508761/), [Phase I/II Study of IPG1094 in Advanced Solid Tumors Patients](https://onco.cc/trials/nct06212076/)

---
JSON: https://onco.cc/api/v1/entities/nanjing-immunophage-biotech.json